Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 100 results in range #41 to #140.

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

  1. Archived: 2010 - 2011 fMRI Reproducibility Call Summaries
  2. Archived: 2010 COPD/Asthma Call Summaries
  3. Archived: 2011 COPD/Asthma Call Summaries
  4. Archived: 2011 CT Volumetry - Group 3A Call Summaries
  5. Archived: 2012 CT Volumetry - Group 3A Call Summaries
  6. Archived: 2012 QIBA US SWS Technical Committee call summaries
  7. Archived: 2012 fMRI Reproducibility Call Summaries
  8. Archived: 2013 fMRI Bias WG Call Summaries
  9. Archived: 2014 fMRI Bias WG Call Summaries
  10. Archived: 2016 Lung Density BC Call Summaries
  11. Archived: fMRI Bias WG Call Summaries
  12. Archived: fMRI Reproducibility Call Summaries
  13. Archived "What is a Profile?" description as of 08.19.2011
  14. Archived - 2010-2011 fMRI Reproducibility Call Summaries
  15. Archived - 2011 fMRI Reproducibility Call Summaries
  16. Archived DCE-MRI Profiles
  17. Archived Versions
  18. Archived Versions of QIBA Vol CT - Group 3A draft documents
  19. Assessment Procedure Guidance
  20. Atherosclerosis Biomarkers Profile Draft Archive
  21. Balloting Process
  22. Bobby test
  23. CEUS BC Call Summaries
  24. CEUS Task Force (TF) Call Summaries
  25. COPD Group Call Summaries
  26. CTV-AD Considerations for Future Editions
  27. CT Acquisition Protocol Groundwork
  28. CT Angiography Biomarker Ctte
  29. CT Angiography Call Summaries Archive
  30. CT Angiography Profile Draft Archive
  31. CT Coordinating Committee
  32. CT Draft Proffered Protocols
  33. CT Small Lung Nodule Biomarker Ctte
  34. CT Volumetry BC Call Summaries Archive
  35. CT Volumetry Biomarker Ctte
  36. Call Agenda Topics
  37. Call Summaries
  38. Call Summaries Archive
  39. Catalog
  40. Change Tracking and File Naming
  41. Claim Confirmation Process
  42. Claim Guidance
  43. Claim Language/Detail
  44. Clinical Applications and Biological Targets Subcommittee
  45. Clinical Sites
  46. Clinical Trial Planning
  47. Clinical Trials Collaboration
  48. Columbia University Medical Center
  49. Combined: System Dependencies & Phantom Development Subcommittees
  50. Combined Nuclear Medicine Biomarker Committee Call Summaries
  51. Comment Resolutions
  52. Committee Organization
  53. Committee Procedures
  54. Committee Sunset Process
  55. Committee Template
  56. Committee on Image Archives
  57. Committee on Open Image Archives
  58. Committees
  59. Communications Committee
  60. Conformity Assessment
  61. Consensus Process
  62. Consensus Protocols
  63. CoreLab Partners, Inc.
  64. CoreLab Partners, Inc., Round-2
  65. Covariates Rationale
  66. DCE-MRI BC Call Summaries Archive
  67. DCE-MRI Project Page
  68. DCE MRI Biomarker Ctte
  69. DSC-MRI Call Summaries Archive
  70. DSC MRI Biomarker Ctte
  71. DTI MRI Biomarker Ctte
  72. DWI Literature Review
  73. DWI MR BC Call Summaries Archive
  74. DWI MR Biomarker Ctte
  75. DWI Profile Development Archive
  76. DWI Profile Draft Archive
  77. Dana-Farber Cancer Institute
  78. David Geffen School of Medicine at UCLA, Department of Radiology
  79. David Geffen School of Medicine at UCLA, Department of Radiology,Round-2
  80. Dept of Research Scatch Page
  81. Digital Reference Objects-Images
  82. Document Archive
  83. Documents / Call Summaries
  84. Dr Tucker's New Test Page
  85. Draft Consensus Protocols
  86. Draft New Main Page
  87. Draft Proffered Protocols
  88. Duke Brain Imaging and Analysis Center
  89. Duke University
  90. Duke University Medical Center
  91. EIBIR/QIBA ASL Biomarker Ctte
  92. Education
  93. Example Use Case for Open Image Archives
  94. Example Use Case for Open Image archives
  95. Executive Committee
  96. Executive Committee Call Summaries Archive
  97. Expressing Requirements
  98. FDG-PET/CT UPICT Template - (Editable)
  99. FDG-PET Archive
  100. FDG-PET Biomarker Ctte

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)